Peptomyc reaches €5M for its cancer drug

AI Briefing

• – Peptomyc's cancer drug reaches €5M funding milestone.
• – Company's co-founder Laura Soucek has spent decades studying the Myc oncogen.
• – Aims to inhibit cancer cell growth by partnering with the oncogen Omomyc.